HAE

Haemonetics Corporation

Price

$108.41

return (12m)

p/e

42.44

p/bv

4.88

DIVIDEND YIELD

0.00%

HAE price

Haemonetics Corporation

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HAE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

39.06%

3 months

75.02%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HAE

Valuation

P/E

42.44

Sector 7.79

Industry 7.79

P/BV

4.88

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.02

Sector 2.22

Industry 2.22

EV/EBITDA

59.50

Sector -156.98

Industry -156.98

EV/EBIT

87.57

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

15.11

Sector 2.51

Industry 2.51

P/EBIT

25.49

Sector 0.34

Industry 0.34

P/Total Assets

1.73

Sector 1.00

Industry 1.00

P/Net Current Assets

-5.70

Sector -3.84

Industry -3.84

P/Working Capital

7.46

Sector -5,077.26

Industry -5,077.26

EPS

2.14

Sector 0.67

Industry 0.67

BVPS

18.60

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

59.03%

Sector 32.61%

Industry 32.61%

EBITDA Margin

24.92%

Sector -284.80%

Industry -284.80%

EBIT Margin

16.93%

Sector -4.02%

Industry -4.02%

Operating Margin

18.12%

Sector 4.45%

Industry 4.45%

Net Profit Margins

7.12%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.14

Sector 0.11

Industry 0.11

Profitability

ROE

11.50%

Sector 2.05%

Industry 2.05%

ROA

4.07%

Sector -0.90%

Industry -0.90%

ROIC

7.82%

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

0.00%

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

3.08

Sector 1.44

Industry 1.44

Net Debt / EBITDA

11.18

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

16.46

Sector -31.03

Industry -31.03

Net Debt / Equity

1.13

Sector -0.72

Industry -0.72

Gross Debt / Equity

1.40

Sector 0.21

Industry 0.21

Equity/Assets

0.35

Sector 0.43

Industry 0.43

Liabilities/Assets

0.65

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

7.24%

Sector -

Industry -

5Y Earnings CAGR

33.62%

Sector -

Industry -

FAIR VALUE OF Haemonetics Corporation ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$108.41

Fair Value

$29.93

Upside Return potential.

-72.40%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HAE

DRAG THE FRAME TO SEE MORE DATA

HAE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Haemonetics Corporation

Haemonetics Corporation

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Haemonetics Corporation (United States) is listed on the Nasdaq and has a market capitalization of $4.09 billion, with shareholders equity totaling $837.10 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Haemonetics Corporation reported $1.35 billion in revenue, generating net income of $96.28 million.

Key financial metrics include a P/E ratio of 42.44, a price-to-book (P/B) ratio of 4.88, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HAE.

Market cap

$4.09 billion

Net worth

$837.10 million

$837,100,000.00

Assets

$2.37 billion

$2,365,400,000.00

Total Shares Outstanding

45.00 million

45,000,000

Average Daily Trading Volume

$843.32 Thousand

$843,318.46

Sector

Others

Industry

Others

HAE

HAE revenue and profits

Financial Results HAE

DRAG THE FRAME TO SEE MORE DATA

HAE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96